89bio Organization
89Bio is a biopharmaceutical company building a pipeline of biologic and small molecule treatments for liver and metabolic disorders.
Total Funding:
£27M
Investor Type:
Healthcare Company
Technology:
Data-driven Technologies
Last Funding Type:
Series A
Estimated Revenue:
$1M to $10M
Founded Date:
2018
Industry:
PharmTech
Employee Number:
11-50
Funding Status:
IPO
Headquarters:
San Francisco, California, United States
Investors Number:
4